This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Lynch BA et al. (2004) The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA 101: 9861–9866
Rogawski M (2006) Diverse mechanisms of antiepileptic drugs in the development pipeline. Epilepsy Res 69: 273–294
Wang MM et al. (2003) Differential distribution and developmental expression of synaptic vesicle protein 2 isoforms in the mouse retina. J Comp Neurol 460: 106–122
Stettler O et al. (1996) Differential synaptic vesicle protein expression in the barrel field of developing cortex. J Comp Neurol 375: 321–332
Acknowledgements
The synopsis was written by Martina Habeck, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Jensen, F., Bourgeois, B. Randomized trial supports use of levetiracetam adjunctive therapy to treat partial seizures in children. Nat Rev Neurol 2, 596–597 (2006). https://doi.org/10.1038/ncpneuro0325
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpneuro0325